Atsuhisa Tamura

Learn More
PURPOSE To investigate the efficacy of erlotinib versus docetaxel in previously treated patients with advanced non-small-cell lung cancer (NSCLC) in an epidermal growth factor receptor (EGFR)(More)
BACKGROUND Performance status (PS) is an important factor in determining survival outcome in non-small cell lung cancer (NSCLC) but is generally confounded by stage, age, gender, and smoking status.(More)
BACKGROUND We previously reported that Asian ethnicity was a favorable prognostic factor for overall survival (OS) in non-small cell lung cancer (NSCLC). In this study, we performed a combined data(More)
BACKGROUND There has been a growing interest in lung cancer in never-smokers. METHODS Utilizing a database from the National Hospital Study Group for Lung Cancer, information for never-smokers and(More)